🔗 Permalink

Inventor profile of:

Lars Thim

City:

Gentofte

Country:

Denmark

Published Applications:

Last publication date:

2018-06-28

Top Assignees for applications by Lars Thim

The entities that hold a legal rights for patent applications filed by inventor Thim Lars:

Novo Nordisk A/S 16 Bagsvaerd, Denmark
Novo Nordisk Health Care AG 1 Zurich, Switzerland
Helsinn Therapeutics (U.S.), Inc. 1 Bridgewater, NJ United States
Novo Nordisk A/S 1 Bagsvaerd, Germany

Recent patent applications by Thim Lars

Lars Thim from Gentofte, DK has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2018-06-28

US20180179262A1

Chemistry; metallurgy

Compounds Suitable for Treatment of Haemophilia

#2 | 2016-11-03

US20160318991A1

Chemistry; metallurgy

Compounds Suitable for Treatment of Haemophilia

#3 | 2016-09-15

US20160264645A1

Chemistry; metallurgy

Stabilized Factor VIII Variants

#4 | 2016-08-04

US20160222086A1

Chemistry; metallurgy

Conjugated Factor VIII Molecules

#5 | 2016-07-21

US20160207977A1

Chemistry; metallurgy

Compounds Suitable for Treatment of Haemophilia

#6 | 2016-05-05

US20160120954A1

Human necessities

Pharmaceutical Composition Suitable for Treatment of Haemophilia

#7 | 2015-03-19

US20150080309A1

Human necessities

Compounds Suitable for Treatment of Haemophilia

#8 | 2015-02-12

US20150045303A1

Chemistry; metallurgy

Pharmaceutical Composition Suitable for Treatment of Haemophilia

#9 | 2014-08-28

US20140242057A1

Chemistry; metallurgy

Conjugated factor VIII molecules

#10 | 2014-01-16

US20140018297A1

Chemistry; metallurgy

Compounds suitable for treatment of haemophilia

#11 | 2013-07-25

US20130189239A1

Chemistry; metallurgy

Conjugated Factor VIII Molecules

#12 | 2013-07-18

US20130183280A1

Chemistry; metallurgy

STABILIZED FACTOR VIII VARIANTS

#13 | 2013-05-30

US20130137638A1

Human necessities

Conjugated factor VIII molecules

#14 | 2011-02-03

US20110028391A1

Human necessities

Use of GLP-1 Peptides

#15 | 2010-08-12

US20100204452A1

Chemistry; metallurgy

Purification of factor VIII using a mixed-mode or multimodal resin

#16 | 2010-07-22

US20100184644A1

Human necessities

MUCOSAL REPAIR BY TFF DIMER PEPTIDES

#17 | 2010-05-06

US20100113363A1

Human necessities

Use of GLP-1 Peptides

#18 | 2009-06-11

US20090149387A1

Human necessities

Use of GLP-1 Peptides

#19 | 2009-01-08

US20090011461A1

Chemistry; metallurgy

Human Spasmolytic Polypeptide in Glycosylated Form

#20 | 2008-11-06

US20080274964A1

Chemistry; metallurgy

Human Spasmolytic Polypeptide in Glycosylated Form

#21 | 2008-08-12

US10685368

GLP-2 compounds, formulations, and uses thereof

#22 | 2008-02-21

US20080045450A1

Chemistry; metallurgy

GLP-2 Derivatives

#23 | 2007-07-12

US20070161568A1

Human necessities

Use of GLP-1 peptides

#24 | 2007-03-22

US20070066540A1

Physics

Growth hormone secretagogue receptor type 1A agonists

#25 | 2007-03-15

US20070060609A1

Human necessities

Identification and Use of Growth Hormone Secretagogue Receptor Type 1A Antagonists

#26 | 2006-12-28

US20060293221A1

Chemistry; metallurgy

Mucosal repair by TFF2 peptides

#27 | 2006-09-21

US20060211605A1

Human necessities

Mucosal repair by TFF dimer peptides

#28 | 2006-05-25

US20060111278A1

Chemistry; metallurgy

TFF peptides

#29 | 2006-05-18

US20060105948A1

Chemistry; metallurgy

GLP-2 derivatives

#30 | 2006-02-23

US20060039862A1

Physics

Identification and use of growth hormone secretagogue receptor type 1A antagonists

#31 | 2006-01-26

US20060019881A1

Chemistry; metallurgy

Human spasmolytic polypeptide in glycosylated form

#32 | 2005-12-29

US20050287640A1

Chemistry; metallurgy

Human spasmolytic polypeptide in glycosylated form

InventorID:

343924 ⎘